Evidence map›Paper›PMID 25147362›Full record

ArticleThe EMBO journal2014

Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death.

Alejandro Martorell-Riera, Marc Segarra-Mondejar, Juan P Muñoz, Vanessa Ginet, Jordi Olloquequi, Jeús Pérez-Clausell, Manuel Palacín, Manuel Reina, Julien Puyal, Antonio Zorzano and 1 more

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 101 citations in OpenAlex.

  1. Increased Expression of Desmin and Vimentin Impairs Mitochondrial Function and Reduces Contractility via G0S2 in Bladder Smooth Muscle.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Review
  4. [Deubiquitinase USP30 alleviates brain injury after intracerebral hemorrhage by regulating MFN2 ubiquitination].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  5. Article
  6. Review
  7. Deficiency ofZoological research · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Biomedical reports · 2024
    Article
  18. Review
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Alejandro Martorell-RieraDepartment of Cell Biology, University of Barcelona, Barcelona, Spain CELLTEC-UB, University of Barcelona, Barcelona, Spain.
Marc Segarra-MondejarDepartment of Cell Biology, University of Barcelona, Barcelona, Spain CELLTEC-UB, University of Barcelona, Barcelona, Spain.
Juan P MuñozDepartment of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Barcelona, Spain Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Instituto de Salud Carlos III, Madrid, Spain.
Vanessa GinetDepartment of Fundamental Neurosciences, Faculty of Biology and Medicine University of Lausanne, Lausanne, Switzerland Clinic of Neonatology, Department of Pediatrics and Pediatric Surgery University Hospital Center and University of Lausanne, Lausanne, Switzerland.
Jordi OlloquequiFacultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
Jeús Pérez-ClausellDepartment of Cell Biology, University of Barcelona, Barcelona, Spain.
Manuel PalacínDepartment of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Barcelona, Spain Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.
Manuel ReinaDepartment of Cell Biology, University of Barcelona, Barcelona, Spain CELLTEC-UB, University of Barcelona, Barcelona, Spain.
Julien PuyalDepartment of Fundamental Neurosciences, Faculty of Biology and Medicine University of Lausanne, Lausanne, Switzerland Clinic of Neonatology, Department of Pediatrics and Pediatric Surgery University Hospital Center and University of Lausanne, Lausanne, Switzerland.
Antonio ZorzanoDepartment of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Barcelona, Spain Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Instituto de Salud Carlos III, Madrid, Spain.
Francesc X SorianoDepartment of Cell Biology, University of Barcelona, Barcelona, Spain CELLTEC-UB, University of Barcelona, Barcelona, Spain f.x.soriano@ub.edu.
Universitat de Barcelona · ESUniversity of Lausanne · CHInstituto de Salud Carlos III · ESUniversidad Autónoma de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial fusion and fission is a dynamic process critical for the maintenance of mitochondrial function and cell viability. During excitotoxicity neuronal mitochondria are fragmented, but the mechanism underlying this process is poorly understood. Here, we show that Mfn2 is the only member of the mitochondrial fusion/fission machinery whose expression is reduced in in vitro and in vivo models of excitotoxicity. Whereas in cortical primary cultures, Drp1 recruitment to mitochondria plays a primordial role in mitochondrial fragmentation in an early phase that can be reversed once the insult has ceased, Mfn2 downregulation intervenes in a delayed mitochondrial fragmentation phase that progresses even when the insult has ceased. Downregulation of Mfn2 causes mitochondrial dysfunction, altered calcium homeostasis, and enhanced Bax translocation to mitochondria, resulting in delayed neuronal death. We found that transcription factor MEF2 regulates basal Mfn2 expression in neurons and that excitotoxicity-dependent degradation of MEF2 causes Mfn2 downregulation. Thus, Mfn2 reduction is a late event in excitotoxicity and its targeting may help to reduce excitotoxic damage and increase the currently short therapeutic window in stroke.

Indexed as

Gene Expression RegulationAnimalsbcl-2-Associated X ProteinCalciumCell DeathCell LineCells, CulturedDown-RegulationDynaminsGTP PhosphohydrolasesHomeostasisHumansMaleMEF2 Transcription FactorsMembrane ProteinsMitochondriaBax protein, ratbcl-2-Associated X ProteinCalciumDnm1l protein, ratDynaminsGTP PhosphohydrolasesMEF2 Transcription FactorsMembrane ProteinsMfn2 protein, ratMitochondrial Proteinsexcitotoxicitymitochondrial dynamicsneurontranscriptional regulation

Identifiers

PMID25147362
PMCPMC4253527
OpenAlexW2169798151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.